News

Mesoblast will supply MPCs manufactured at Singapore manufacturing facility of its contract manufacturer, Lonza, besides at its US facility. Mesoblast chief executive Professor Silviu Itescu said, "Having multiple

The progression of the compound into pre-clinical development has triggered a milestone payment to Evotec from Ono, as per the deal signed between the companies in March 2008.

As per the deal, RQx will earn an up-front payment in addition to research and development milestone payments worth $111m. RQx CEO and venture partner at Avalon Venture

The collaboration will focus on developing small-molecule therapies directed to select new targets to treat autoimmune diseases. Lycera president and chief executive officer Kathleen Metters said, "Lycera’s proven

Sobi gained distribution rights in Ireland, United Kingdom, France, Italy, Germany, Spain, Finland, Sweden, Denmark, Norway, Austria, Belgium, Liechtenstein, Netherlands, Portugal, and Luxembourg. The distribution is expected to

Agilent’s commercial products include RapidFire system, designed for use in pharmaceutical and biopharmaceutical laboratories. Agilent RapidFire business director Can Ozbal said, "By using multiple RapidFire systems Ameritox is

The companies collaborated to integrate expertise in biology, advanced chemistry and technology commercialization for algae based products. Qualitas Health CTO Dr. Isaac Berzin said, "Exclusive access to Valicor’s

Geo Vision developed weight loss supplement as a dietary aid for the adults considered obese in the US. The weight loss supplement that contains natural supplement of Acai

CBPE acquired Rosemont in August 2006 for £93m. The sale to Perrigo represents an investment multiple of 3.25x CBPE’s £52m equity investment over the investment period for CBPE’s